Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1998
05/12/1998US5750725 Hemoglobin crosslinkers
05/12/1998US5750696 Dioxacycloalkane compound having renin-inhibitory activity
05/12/1998US5750692 Alkylating cyano-1-(3,5-di-o-p-toluoyl-beta-d-pentose)imidazole in base, ammonolyating, cyclizing
05/12/1998US5750687 Angiotensin converting enzyme inhibitors, neutral endopeptidase inhibitors
05/12/1998US5750678 Water-soluble dextran fatty acid esters and their use as solubilizers
05/12/1998US5750665 Preparation of glucosaminyl muramic acid derivatives
05/12/1998US5750658 Fibrinogen processing apparatus, method and container
05/12/1998US5750657 Methods and compositions using fibrin monomer to make a fibrin sealant
05/12/1998US5750654 Leukaemia inhibitory factor
05/12/1998US5750653 Protein, FAF1, which potentiates Fas-mediated apoptosis and uses thereof
05/12/1998US5750652 Deltex proteins
05/12/1998US5750651 Cartilage and bone-inducing proteins
05/12/1998US5750648 Retroviral protease inhibitors and combinations thereof
05/12/1998US5750646 Anticarcinogenic agents; antiinflammatory agents
05/12/1998US5750571 Methods and therapeutic compositions for treating cystic fibrosis
05/12/1998US5750557 Method and pharmaceutical formulation for treating benign prostatic hyperplasia
05/12/1998US5750521 Mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE
05/12/1998US5750520 Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives
05/12/1998US5750519 Administering dopamine antagonist and prolactin stimulator
05/12/1998US5750509 Amide derivatives of antibiotic A 40926
05/12/1998US5750506 Treating inflammation, head trauma, pain, asthma
05/12/1998US5750503 Administering synergistic mixture of granulocyte colony stimulating factor (g-csf) and tumor necrosis factor binding protein (tnf-bp) lacking first domain of constant region of heavy chain of human immunoglobulin igg1 or igg3
05/12/1998US5750502 Cloning, expression and uses of a secreted protein, F-spondin
05/12/1998US5750501 Method and composition for treatment of patients having decompensated liver disease
05/12/1998US5750499 Antitumor
05/12/1998US5750497 Water solublity
05/12/1998US5750496 Method of controlling cryptosporidium infectons using protease inhibitors
05/12/1998US5750495 Administering tumor necrosis factor
05/12/1998US5750493 Alpha-1-acid glycoprotein binders
05/12/1998US5750398 Vector, element and method for inhibiting immune recognition
05/12/1998US5750397 Human hematopoietic stem cell
05/12/1998US5750395 DNA encoding MAGE-1 C-terminal cytotoxic t lymphocyte immunogenic peptides
05/12/1998US5750394 Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
05/12/1998US5750391 Filariid nematode cysteine protease proteins
05/12/1998US5750387 DNA encoing leucyl TRNA synthetase from staphylococcus aureus
05/12/1998US5750378 Method for preparing cellular fibronectin
05/12/1998US5750377 Process for preparing mammalian T cell growth factor P40
05/12/1998US5750376 In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
05/12/1998US5750371 Water-soluble mutein of FGF receptor, DNA and production thereof
05/12/1998US5750370 Genetic engineering
05/12/1998US5750369 DNA encoding a prostaglandin F28 receptor, a host cell transformed therewith and an expression product thereof
05/12/1998US5750367 Cardiovascular
05/12/1998US5750366 Cloning and expression of gonadotropin-releasing hormone receptor
05/12/1998US5750365 Isolated nucleic acid encoding a newt acidic fibroblast growth factor (AFGF)
05/12/1998US5750353 Assay for non-peptide agonists to peptide hormone receptors
05/12/1998US5750351 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
05/12/1998US5750349 Diagnostic composition for alzheimer's disease
05/12/1998US5750342 Contacting mixture of nucleic acids with target comprising blood cells, fibrin clots, carotid arteries, partitioning high affinity nucleic acids from remainder of mixture, amplifying to yield mixture enriched in high affinity nucleic acids
05/12/1998US5750176 Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
05/12/1998US5750148 Cellulosic enteric base
05/12/1998US5750144 Oral administration of subdivided and sterilized, undenatured water-insoluble type ii collagen extracted from animal cartilage
05/12/1998US5750132 Adinistering extracellular, recombinant hemoglobin to treat disorders resulting from radiation, anemia, tissue ischemia
05/12/1998US5750119 Immunotherapeutic stress protein-peptide complexes against cancer
05/12/1998US5750110 Vaccine composition containing adjuvants
05/12/1998US5750106 Treating infections
05/12/1998US5750105 Recombinant antibodies for human therapy
05/12/1998US5750104 Buffer added for side effect reduction while maintaining enzyme activity
05/12/1998US5750103 Method for transplanting cells into the brain and therapeutic uses therefor
05/12/1998US5750100 Drug delivery of an active peptide or protein by injection or implantation by incorporating in a matrix of a polyglycerol diester of a saturated fatty acid; nondenaturing; antiallergens
05/12/1998US5750088 Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals
05/12/1998US5750078 Side effect reduction
05/12/1998US5749968 Device for priming for improved adherence of gels to substrates
05/12/1998US5749847 Delivery of nucleotides into organisms by electroporation
05/12/1998CA2205045A1 Factors and methods for reducing biological activity of a multimeric protein and methods of screening therefor
05/12/1998CA2190056A1 Pharmaceutical composition for prophylaxis or treatment of cerebral vasospasm
05/12/1998CA2010312C Peptide derivatives and their pharmaceutical use
05/12/1998CA1339868C Serum immunoregulatory polypeptide and uses therefor
05/07/1998WO1998018960A1 Process aimed at evidencing the state of a malignant cell and process for treatment
05/07/1998WO1998018951A1 Receptor-mediated gene transfer system for targeting tumor gene therapy
05/07/1998WO1998018947A1 Methods for the characterization and selection of rna target motifs that bind compounds of pharmaceutical use
05/07/1998WO1998018945A1 Reagents and methods useful for detecting diseases of the breast
05/07/1998WO1998018942A2 Novel human rab proteins
05/07/1998WO1998018938A1 Novel human spermidine/spermine n1-acetyltransferase
05/07/1998WO1998018934A1 Therapeutic gene
05/07/1998WO1998018931A2 Streptococcus pneumoniae polynucleotides and sequences
05/07/1998WO1998018930A2 Streptococcus pneumoniae antigens and vaccines
05/07/1998WO1998018928A1 Immunogenic detoxified mutant e. coli lt-a toxin
05/07/1998WO1998018926A1 Circularly permuted erythropoietin receptor agonists
05/07/1998WO1998018925A2 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids
05/07/1998WO1998018924A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists
05/07/1998WO1998018923A1 NOVEL flt-3 RECEPTOR AGONISTS
05/07/1998WO1998018922A1 Human phosphoprotein
05/07/1998WO1998018921A1 NEUTROKINE $g(a)
05/07/1998WO1998018919A2 Gabaa receptor subunit epsilon-related protein
05/07/1998WO1998018918A1 Stable expression of triple helical proteins
05/07/1998WO1998018916A1 Human p2x purinoreceptor
05/07/1998WO1998018915A2 Method for selective and irreversible cross-linking of platinized oiligonucleotides on rna and its applications
05/07/1998WO1998018914A1 Soluble tie2 receptor
05/07/1998WO1998018911A1 Human guanylate-binding proteins
05/07/1998WO1998018826A2 Anti-ccr5 antibodies and methods of use therefor
05/07/1998WO1998018825A1 Anti-p53 single-chain antibody fragments and their uses
05/07/1998WO1998018824A1 Human tumor necrosis factor receptor-like 2
05/07/1998WO1998018823A1 Ice inhibiting peptides
05/07/1998WO1998018822A2 Novel human lim proteins
05/07/1998WO1998018820A1 Methods and compositions for ricin fusion protein immunotoxins to treat cancer and autoimmune disease
05/07/1998WO1998018818A2 Hepatitis b inhibitors
05/07/1998WO1998018816A1 Peptide compositions with growth factor-like activity
05/07/1998WO1998018812A1 Oligomers which inhibit the expression of interleukin genes
05/07/1998WO1998018811A1 Delivery construct for antisense nucleic acids and methods of use
05/07/1998WO1998018809A1 Targeted cytolysis of cancer cells
1 ... 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 ... 3163